A £45 million boost to data and building infrastructure will support major advances in areas such as drug discovery, cancer genetics, regenerative medicine and crop disease prevention over the coming decades.
Bioinformatics – the science of analysing, storing and sharing large biological datasets – is essential to discovering how genes affect the health of humans, plants and animals.
EMBL’s European Bioinformatics Institute (EMBL-EBI), in Cambridgeshire, is a renowned global leader in bioinformatics. Life scientists all over the world use EMBL-EBI’s infrastructure to share and access data to drive cutting-edge research in genomics and molecular biology.
Click for full story
Submitted on 11/04/2019